How should a safe and effective COVID-19 vaccine be allocated? Health economists need to be ready to take the baton
Autores principales: | Roope, LSJ, Buckell, J, Becker, F, Candio, P, Violato, M, Sindelar, JL, Barnett, A, Raymond Duch, Clarke, PM |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Springer Nature
2020
|
Ejemplares similares
-
Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities
por: Duch, R, et al.
Publicado: (2021) -
Is there broad-based support in high-income countries for COVID-19 vaccine donation? Evidence from seven countries
por: Roope, LSJ, et al.
Publicado: (2021) -
Prevalence, predictors and reasons for COVID-19 vaccine hesitancy: results of a global online survey
por: Candio, P, et al.
Publicado: (2023) -
Lessons from the pandemic on the value of research infrastructure
por: Roope, LSJ, et al.
Publicado: (2021) -
Should flavours be banned in cigarettes and e-cigarettes? Evidence on adult smokers and recent quitters from a discrete choice experiment
por: Buckell, J, et al.
Publicado: (2018)